Larimar Therapeutics to Present at the 34th Annual Piper Sandler Healthcare Conference
BALA CYNWYD, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that company management will present and participate in 1x1 investor meetings at the 34th Annual Piper Sandler Healthcare Conference, which is taking place in New York, NY from November 29 – December 1, 2022. The Company’s presentation will take place on Thursday, December 1, 2022, at 10:10 AM ET.
About Larimar Therapeutics
Enabling Blockchains to Comply with â€œRight to Be Forgotten"
Next Generation Architectures